Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
B1 Floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8921- Is this information wrong?
Summary
- Dr. Bryan Schneider is an oncologist in Ann Arbor, MI and is affiliated with Michigan Medicine. He received his medical degree from Indiana University School of Medicine and has been in practice 19 years. He specializes in hematologic oncology and is experienced in medical oncology, thoracic oncology, general medical oncology, and lung neoplasms.
Education & Training
- University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2005
- Indiana University School of MedicineResidency, Internal Medicine, 1998 - 2002
- Indiana University School of MedicineClass of 1998
Certifications & Licensure
- MI State Medical License 2002 - 2027
- NY State Medical License 2008 - 2016
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors Start of enrollment: 2009 Jul 01
- BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 1 citationsPneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.Gabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, Yang Lu, Mehmet Altan, Yan Zhou, Dan Zhao, Enrico N De Toni, Helga-Paula Török, Bryan J Schneider, Anam K...> ;Journal of Cancer Research and Clinical Oncology. 2023 Dec 1
- 1 citationsA Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.Angel Qin, Leah Wells, Binu Malhotra, Shirish Gadgeel, Bryan J Schneider, Nithya Ramnath, John D Rice, Gregory P Kalemkerian> ;Clinical Lung Cancer. 2024 Mar 1
- 1 citationsEffects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity.Malek Shatila, Weijie Ma, Yantong Cui, Sidra Naz, Anusha S Thomas, Enrico N De Toni, Helga-Paula Török, Najib Ben Khaled, Mehmet Altan, Yinghong Wang, Bryan Schneider> ;Journal of Cancer Research and Clinical Oncology. 2023 Aug 1
- Join now to see all
Lectures
- Implications of incidental germline findings identified in the context of clinical whole exome sequencing (WES) for guiding cancer therapy.2019 ASCO Annual Meeting - 6/1/2019
- Review and Interpretation of the 2012 San Antonio Breast Cancer SymposiumIndiana University School of Medicine, Indianapolis, Indiana - 1/19/2013
Press Mentions
- Manatt Expands National Health Care Capabilities with Arrival of Prominent Litigator in ChicagoOctober 7th, 2021
- ASCO Endorses ASTRO Guideline on Stereotactic Body Radiotherapy for Early-Stage NSCLCNovember 16th, 2017
Professional Memberships
- Member
Hospital Affiliations
- University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: